Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

BACKGROUND: There are limited long-term outcome data in eculizumab-treated patients with atypical hemolytic uremic syndrome (aHUS). We report final results from the largest prospective, observational, multicenter study of patients with aHUS treated with eculizumab. METHODS: Patients with aHUS who pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Menne, Jan, Delmas, Yahsou, Fakhouri, Fadi, Licht, Christoph, Lommelé, Åsa, Minetti, Enrico E., Provôt, François, Rondeau, Eric, Sheerin, Neil S., Wang, Jimmy, Weekers, Laurent E., Greenbaum, Larry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456946/
https://www.ncbi.nlm.nih.gov/pubmed/30971227
http://dx.doi.org/10.1186/s12882-019-1314-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456946/
https://www.ncbi.nlm.nih.gov/pubmed/30971227
http://dx.doi.org/10.1186/s12882-019-1314-1

Ejemplares similares